Lonza Group

Lonza Group

Community score

+0.96 -55
SASB Industry: Biotechnology & Pharmaceuticals
Listing country: Switzerland
Year added: 2018

Founded in 1897, Lonza is a multinational company with its headquarters in Basel, Switzerland. The company is primarily divided into two main business segments: Pharma Biotech & Nutrition and Specialty Ingredients. The Pharma Biotech & Nutrition segment offers custom development and manufacturing services for pharmaceutical and biotechnology companies, as well as ingredients for nutrition purposes. Meanwhile, the Specialty Ingredients segment provides a range of products and services designed for consumer health and a variety of industrial applications. Lonza's business is characterized by its business-to-business relationships, focusing on providing tailored manufacturing solutions and ingredients rather than selling through heavily promoted consumer brands. Nevertheless, the company owns several brands, with Capsugel being one of the most notable for its innovative capsules and dosage form solutions. As a global entity, Lonza markets its products and services across the world, with a significant presence in key markets such as the United States, Europe, and Asia. Despite the global spread of Lonza's sales, the company does not specify a list of the most important countries where its products and services are sold. (Powered by AI)

Show Company Information
You view a limited profile page without scores and metrics availability. Subscribing users get to see more advanced data, want to see it in action? Click on a company you are interested in: .
List View

Most negative / positive SDG

+3.60
-3.79